Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study

Abstract
Objective We sought to determine the extent of SARS-CoV-2 seroprevalence and the factors associated with seroprevalence across a diverse cohort of healthcare workers. Design Observational cohort study of healthcare workers, including SARS-CoV-2 serology testing and participant questionnaires. Settings A multisite healthcare delivery system located in Los Angeles County. Participants A diverse and unselected population of adults (n=6062) employed in a multisite healthcare delivery system located in Los Angeles County, including individuals with direct patient contact and others with non-patient-oriented work functions. Main outcomes Using Bayesian and multivariate analyses, we estimated seroprevalence and factors associated with seropositivity and antibody levels, including pre-existing demographic and clinical characteristics; potential COVID-19 illness-related exposures; and symptoms consistent with COVID-19 infection. Results We observed a seroprevalence rate of 4.1%, with anosmia as the most prominently associated self-reported symptom (OR 11.04, pConclusion and relevance The demographic factors associated with SARS-CoV-2 seroprevalence among our healthcare workers underscore the importance of exposure sources beyond the workplace. The size and diversity of our study population, combined with robust survey and modelling techniques, provide a vibrant picture of the demographic factors, exposures and symptoms that can identify individuals with susceptibility as well as potential to mount an immune response to COVID-19.
Funding Information
  • Cedars-Sinai Medical Center
  • Erika J. Glazer Family Foundation
  • National Cancer Institute (U54-CA260591)
  • National Heart, Lung, and Blood Institute (K23-HL153888)